

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.37819688 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.37819688 |
| 3 | detection of other organism (GO:0098543) | 4.20480844 |
| 4 | detection of bacterium (GO:0016045) | 4.02635197 |
| 5 | detection of external biotic stimulus (GO:0098581) | 3.88188275 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 3.82672598 |
| 7 | low-density lipoprotein particle clearance (GO:0034383) | 3.79516543 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59691585 |
| 9 | apoptotic cell clearance (GO:0043277) | 3.49439980 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48848203 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.48848203 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 3.48331740 |
| 13 | detection of biotic stimulus (GO:0009595) | 3.35656456 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 3.33925393 |
| 15 | protein carboxylation (GO:0018214) | 3.32693249 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.32693249 |
| 17 | regulation of cholesterol storage (GO:0010885) | 3.19502109 |
| 18 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.18102559 |
| 19 | barbed-end actin filament capping (GO:0051016) | 3.15570660 |
| 20 | complement activation, alternative pathway (GO:0006957) | 3.15491235 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.09957839 |
| 22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07105647 |
| 23 | cellular extravasation (GO:0045123) | 3.03391779 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03387596 |
| 25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01946668 |
| 26 | response to host (GO:0075136) | 3.01946668 |
| 27 | response to host defenses (GO:0052200) | 3.01946668 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 3.01067272 |
| 29 | plasma lipoprotein particle clearance (GO:0034381) | 3.00162650 |
| 30 | epoxygenase P450 pathway (GO:0019373) | 2.97075891 |
| 31 | response to host immune response (GO:0052572) | 2.96932177 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96932177 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95916557 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 2.94682128 |
| 35 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.92135321 |
| 36 | regulation of leukocyte degranulation (GO:0043300) | 2.91182797 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 2.90908256 |
| 38 | macrophage activation (GO:0042116) | 2.90063367 |
| 39 | primary alcohol catabolic process (GO:0034310) | 2.87099552 |
| 40 | response to type I interferon (GO:0034340) | 2.86373158 |
| 41 | cellular response to type I interferon (GO:0071357) | 2.86322340 |
| 42 | type I interferon signaling pathway (GO:0060337) | 2.86322340 |
| 43 | valine metabolic process (GO:0006573) | 2.85342471 |
| 44 | leukocyte aggregation (GO:0070486) | 2.84098039 |
| 45 | regulation of protein activation cascade (GO:2000257) | 2.81922127 |
| 46 | neutrophil activation (GO:0042119) | 2.79924871 |
| 47 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.77554726 |
| 48 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.77482447 |
| 49 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.76920865 |
| 50 | regulation of complement activation (GO:0030449) | 2.76168837 |
| 51 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.74578194 |
| 52 | germinal center formation (GO:0002467) | 2.72189085 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.71640875 |
| 54 | granulocyte activation (GO:0036230) | 2.71342457 |
| 55 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.70558861 |
| 56 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.70558861 |
| 57 | modulation by symbiont of host immune response (GO:0052553) | 2.70558861 |
| 58 | positive regulation by symbiont of host defense response (GO:0052509) | 2.70558861 |
| 59 | modulation by symbiont of host defense response (GO:0052031) | 2.70558861 |
| 60 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.70558861 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.70483095 |
| 62 | hormone catabolic process (GO:0042447) | 2.69967927 |
| 63 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.68684880 |
| 64 | response to interferon-alpha (GO:0035455) | 2.68019343 |
| 65 | response to muramyl dipeptide (GO:0032495) | 2.66723176 |
| 66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.66032177 |
| 67 | basement membrane organization (GO:0071711) | 2.65117361 |
| 68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.65051651 |
| 69 | protein localization to endosome (GO:0036010) | 2.63105844 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63015238 |
| 71 | regulation of apoptotic cell clearance (GO:2000425) | 2.62144471 |
| 72 | microglial cell activation (GO:0001774) | 2.60102610 |
| 73 | regulation of triglyceride catabolic process (GO:0010896) | 2.59851211 |
| 74 | regulation of gamma-delta T cell activation (GO:0046643) | 2.59780425 |
| 75 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.59426775 |
| 76 | pentose-phosphate shunt (GO:0006098) | 2.59303710 |
| 77 | respiratory burst (GO:0045730) | 2.58138759 |
| 78 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.55496755 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 2.54927615 |
| 80 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.54901704 |
| 81 | mannose metabolic process (GO:0006013) | 2.54616949 |
| 82 | positive regulation of hemostasis (GO:1900048) | 2.54397940 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 2.54397940 |
| 84 | myeloid cell activation involved in immune response (GO:0002275) | 2.54019695 |
| 85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.53229230 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.52556891 |
| 87 | regulation of fibrinolysis (GO:0051917) | 2.51416584 |
| 88 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.50390139 |
| 89 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.49558745 |
| 90 | phospholipid efflux (GO:0033700) | 2.48621410 |
| 91 | keratan sulfate catabolic process (GO:0042340) | 2.48279412 |
| 92 | negative regulation of innate immune response (GO:0045824) | 2.47603867 |
| 93 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.47009389 |
| 94 | phagocytosis, recognition (GO:0006910) | 2.46606051 |
| 95 | acute-phase response (GO:0006953) | 2.46557083 |
| 96 | response to peptidoglycan (GO:0032494) | 2.46478754 |
| 97 | positive regulation of coagulation (GO:0050820) | 2.46431584 |
| 98 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.46206686 |
| 99 | NADPH regeneration (GO:0006740) | 2.46199386 |
| 100 | regulation of T cell tolerance induction (GO:0002664) | 2.46153766 |
| 101 | high-density lipoprotein particle remodeling (GO:0034375) | 2.46031314 |
| 102 | polyketide metabolic process (GO:0030638) | 2.45017026 |
| 103 | doxorubicin metabolic process (GO:0044598) | 2.45017026 |
| 104 | daunorubicin metabolic process (GO:0044597) | 2.45017026 |
| 105 | fibrinolysis (GO:0042730) | 2.44907918 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44822888 |
| 107 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.44713050 |
| 108 | positive regulation of interferon-alpha production (GO:0032727) | 2.44698240 |
| 109 | NIK/NF-kappaB signaling (GO:0038061) | 2.43128072 |
| 110 | detection of molecule of bacterial origin (GO:0032490) | 2.42943888 |
| 111 | pinocytosis (GO:0006907) | 2.42632473 |
| 112 | regulation of necroptotic process (GO:0060544) | 2.42489450 |
| 113 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.41745914 |
| 114 | reverse cholesterol transport (GO:0043691) | 2.41712925 |
| 115 | regulation of antigen processing and presentation (GO:0002577) | 2.41580231 |
| 116 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.41181329 |
| 117 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.40818397 |
| 118 | regulation of macrophage cytokine production (GO:0010935) | 2.40312655 |
| 119 | regulation of extracellular matrix disassembly (GO:0010715) | 2.39768752 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 2.39678530 |
| 121 | negative regulation of phagocytosis (GO:0050765) | 2.39568020 |
| 122 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.39311207 |
| 123 | negative regulation of type 2 immune response (GO:0002829) | 2.38963630 |
| 124 | immunoglobulin mediated immune response (GO:0016064) | 2.38900397 |
| 125 | T-helper 1 type immune response (GO:0042088) | 2.37297780 |
| 126 | L-phenylalanine metabolic process (GO:0006558) | 2.37283449 |
| 127 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.37283449 |
| 128 | adhesion of symbiont to host (GO:0044406) | 2.36487175 |
| 129 | skin morphogenesis (GO:0043589) | 2.35961853 |
| 130 | endodermal cell differentiation (GO:0035987) | 2.35651135 |
| 131 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.35059437 |
| 132 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.34827230 |
| 133 | regulation of tolerance induction (GO:0002643) | 2.34586355 |
| 134 | urea cycle (GO:0000050) | 2.34451740 |
| 135 | urea metabolic process (GO:0019627) | 2.34451740 |
| 136 | positive regulation of antigen processing and presentation (GO:0002579) | 2.34403599 |
| 137 | positive regulation of lipid catabolic process (GO:0050996) | 2.34335316 |
| 138 | plasma lipoprotein particle remodeling (GO:0034369) | 2.34045400 |
| 139 | protein-lipid complex remodeling (GO:0034368) | 2.34045400 |
| 140 | macromolecular complex remodeling (GO:0034367) | 2.34045400 |
| 141 | macrophage activation involved in immune response (GO:0002281) | 2.33978834 |
| 142 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.33360447 |
| 143 | lipoprotein metabolic process (GO:0042157) | 2.33332671 |
| 144 | stress fiber assembly (GO:0043149) | 2.33179923 |
| 145 | regulation of cellular extravasation (GO:0002691) | 2.32376765 |
| 146 | cell adhesion mediated by integrin (GO:0033627) | 2.32039314 |
| 147 | positive regulation of p38MAPK cascade (GO:1900745) | 2.31941980 |
| 148 | defense response to protozoan (GO:0042832) | 2.31712113 |
| 149 | regulation of necrotic cell death (GO:0010939) | 2.31297965 |
| 150 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.30461826 |
| 151 | regulation of regulated secretory pathway (GO:1903305) | 2.29976035 |
| 152 | L-phenylalanine catabolic process (GO:0006559) | 2.28434111 |
| 153 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.28434111 |
| 154 | * positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.28404639 |
| 155 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.27986129 |
| 156 | response to laminar fluid shear stress (GO:0034616) | 2.27931738 |
| 157 | regulation of interferon-alpha production (GO:0032647) | 2.27531052 |
| 158 | negative regulation of interleukin-8 production (GO:0032717) | 2.27273997 |
| 159 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.26471101 |
| 160 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.25659690 |
| 161 | regulation of type 2 immune response (GO:0002828) | 2.25461712 |
| 162 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.25441185 |
| 163 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.25166205 |
| 164 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.24501872 |
| 165 | hyaluronan catabolic process (GO:0030214) | 2.24197664 |
| 166 | negative regulation of granulocyte differentiation (GO:0030853) | 2.24187037 |
| 167 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.23705166 |
| 168 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.23705166 |
| 169 | opsonization (GO:0008228) | 2.23165097 |
| 170 | positive regulation of receptor recycling (GO:0001921) | 2.22727204 |
| 171 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.22142648 |
| 172 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.22122886 |
| 173 | glyoxylate metabolic process (GO:0046487) | 2.20332425 |
| 174 | negative regulation of lipid storage (GO:0010888) | 2.20000387 |
| 175 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.19723320 |
| 176 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.18787658 |
| 177 | xenobiotic catabolic process (GO:0042178) | 2.18785633 |
| 178 | coenzyme catabolic process (GO:0009109) | 2.18522862 |
| 179 | positive regulation of histone deacetylation (GO:0031065) | 2.17870304 |
| 180 | regulation of cholesterol esterification (GO:0010872) | 2.17558914 |
| 181 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.17027155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.65368053 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.36569270 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.35765640 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.12559880 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42292630 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.20603741 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.06884653 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68369253 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.55527169 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.51767912 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50978177 |
| 12 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.35849689 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.32892735 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.28779219 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27492297 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.24823796 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18504629 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13019534 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07626643 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06623204 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01346175 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01320798 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.99835781 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94853182 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94712076 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94245955 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92687496 |
| 28 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86833771 |
| 29 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.83481562 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73655940 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71869967 |
| 32 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70285377 |
| 33 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64916266 |
| 34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.62318203 |
| 35 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.61367584 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58433839 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.56979483 |
| 38 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.56765242 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.55673684 |
| 40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.51554336 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50791648 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49478159 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46399434 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43639104 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42266468 |
| 46 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.42213174 |
| 47 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.42213174 |
| 48 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.42213174 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41125058 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41029599 |
| 51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38942795 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.36985136 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36853020 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36832739 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34176295 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32863368 |
| 57 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32788526 |
| 58 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32469771 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29224409 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28427626 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.28004155 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27749679 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26107514 |
| 64 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25626598 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24617585 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.23456279 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.23087263 |
| 68 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23018718 |
| 69 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22856307 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22298747 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20887492 |
| 72 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17539052 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17102355 |
| 74 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16826765 |
| 75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15338416 |
| 76 | MYC_22102868_ChIP-Seq_BL_Human | 1.13575381 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13388633 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13368413 |
| 79 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13193170 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13143471 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12804689 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12174767 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10894318 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10889016 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10657919 |
| 86 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.10447419 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10168439 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10106217 |
| 89 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09991714 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09554558 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08019638 |
| 92 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.07387087 |
| 93 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06917576 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06851059 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06745320 |
| 96 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.04065810 |
| 97 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03955491 |
| 98 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03226314 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02522284 |
| 100 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01381466 |
| 101 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01327687 |
| 102 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00963340 |
| 103 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00452294 |
| 104 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00100917 |
| 105 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00006188 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99636305 |
| 107 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98843246 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98798279 |
| 109 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.98370272 |
| 110 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.97652594 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96964181 |
| 112 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.96377077 |
| 113 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96089901 |
| 114 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95537608 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94065793 |
| 116 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91889689 |
| 117 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90892099 |
| 118 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90892099 |
| 119 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90740121 |
| 120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90634871 |
| 121 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.89779567 |
| 122 | MYB_26560356_Chip-Seq_TH1_Human | 0.89194203 |
| 123 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87363776 |
| 124 | * MYB_26560356_Chip-Seq_TH2_Human | 0.86385552 |
| 125 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.86195631 |
| 126 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.85992044 |
| 127 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85553926 |
| 128 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83539810 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82361219 |
| 130 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.80709605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.57493906 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.45719473 |
| 3 | MP0005360_urolithiasis | 2.68002907 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.57232816 |
| 5 | MP0009840_abnormal_foam_cell | 2.41286061 |
| 6 | MP0005275_abnormal_skin_tensile | 2.38613517 |
| 7 | MP0003724_increased_susceptibility_to | 2.37111240 |
| 8 | MP0002254_reproductive_system_inflammat | 2.34881465 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.29801253 |
| 10 | MP0010368_abnormal_lymphatic_system | 2.06127273 |
| 11 | MP0005365_abnormal_bile_salt | 1.95144178 |
| 12 | MP0005451_abnormal_body_composition | 1.92609391 |
| 13 | * MP0003436_decreased_susceptibility_to | 1.88636243 |
| 14 | MP0003300_gastrointestinal_ulcer | 1.88206066 |
| 15 | MP0003566_abnormal_cell_adhesion | 1.86799357 |
| 16 | MP0003279_aneurysm | 1.85298650 |
| 17 | MP0008260_abnormal_autophagy | 1.79089061 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 1.76171024 |
| 19 | MP0003303_peritoneal_inflammation | 1.75900779 |
| 20 | MP0005023_abnormal_wound_healing | 1.70672139 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.70668785 |
| 22 | MP0006082_CNS_inflammation | 1.66747368 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.64905903 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.63017519 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.60121236 |
| 26 | MP0003252_abnormal_bile_duct | 1.59499892 |
| 27 | * MP0002420_abnormal_adaptive_immunity | 1.56364687 |
| 28 | * MP0001819_abnormal_immune_cell | 1.55995249 |
| 29 | MP0006054_spinal_hemorrhage | 1.54425754 |
| 30 | * MP0009785_altered_susceptibility_to | 1.52326992 |
| 31 | MP0004272_abnormal_basement_membrane | 1.51874239 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.48921684 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.43223387 |
| 34 | MP0002060_abnormal_skin_morphology | 1.42323407 |
| 35 | MP0009278_abnormal_bone_marrow | 1.42260581 |
| 36 | MP0001958_emphysema | 1.41638164 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.40655221 |
| 38 | * MP0002419_abnormal_innate_immunity | 1.39292689 |
| 39 | * MP0001533_abnormal_skeleton_physiology | 1.38636624 |
| 40 | MP0004947_skin_inflammation | 1.38252374 |
| 41 | * MP0000343_altered_response_to | 1.37517547 |
| 42 | MP0005671_abnormal_response_to | 1.35928857 |
| 43 | * MP0005025_abnormal_response_to | 1.35084557 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.34448851 |
| 45 | MP0000685_abnormal_immune_system | 1.34421896 |
| 46 | * MP0000609_abnormal_liver_physiology | 1.27753948 |
| 47 | MP0005083_abnormal_biliary_tract | 1.27505084 |
| 48 | MP0003011_delayed_dark_adaptation | 1.27002198 |
| 49 | MP0001853_heart_inflammation | 1.26329945 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.25998183 |
| 51 | MP0000604_amyloidosis | 1.22329137 |
| 52 | MP0005503_abnormal_tendon_morphology | 1.20344682 |
| 53 | MP0005166_decreased_susceptibility_to | 1.18398935 |
| 54 | MP0000858_altered_metastatic_potential | 1.16899267 |
| 55 | MP0001542_abnormal_bone_strength | 1.15574844 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.14530775 |
| 57 | * MP0005319_abnormal_enzyme/_coenzyme | 1.14378622 |
| 58 | MP0001879_abnormal_lymphatic_vessel | 1.13809801 |
| 59 | MP0003448_altered_tumor_morphology | 1.13292108 |
| 60 | * MP0008469_abnormal_protein_level | 1.13148773 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.11763680 |
| 62 | MP0005670_abnormal_white_adipose | 1.11707499 |
| 63 | MP0003186_abnormal_redox_activity | 1.11590149 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.10607942 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.09253811 |
| 66 | MP0008004_abnormal_stomach_pH | 1.09009121 |
| 67 | MP0005257_abnormal_intraocular_pressure | 1.08347695 |
| 68 | * MP0005000_abnormal_immune_tolerance | 1.08232731 |
| 69 | * MP0000716_abnormal_immune_system | 1.08144810 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.06892419 |
| 71 | * MP0009764_decreased_sensitivity_to | 1.06860622 |
| 72 | MP0003866_abnormal_defecation | 1.06647809 |
| 73 | MP0000767_abnormal_smooth_muscle | 1.04721996 |
| 74 | MP0003828_pulmonary_edema | 1.03842491 |
| 75 | * MP0002148_abnormal_hypersensitivity_rea | 1.02971112 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.02548094 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.02548094 |
| 78 | MP0001243_abnormal_dermal_layer | 1.02529001 |
| 79 | MP0002132_abnormal_respiratory_system | 1.02140609 |
| 80 | MP0000249_abnormal_blood_vessel | 1.02116773 |
| 81 | * MP0001845_abnormal_inflammatory_respons | 1.00297596 |
| 82 | * MP0005390_skeleton_phenotype | 0.99016439 |
| 83 | MP0004185_abnormal_adipocyte_glucose | 0.98832643 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.96811003 |
| 85 | MP0002398_abnormal_bone_marrow | 0.95435956 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 0.94887101 |
| 87 | * MP0002452_abnormal_antigen_presenting | 0.93455089 |
| 88 | MP0002166_altered_tumor_susceptibility | 0.93272441 |
| 89 | MP0003329_amyloid_beta_deposits | 0.93185217 |
| 90 | * MP0005387_immune_system_phenotype | 0.92511575 |
| 91 | * MP0001790_abnormal_immune_system | 0.92511575 |
| 92 | MP0004883_abnormal_blood_vessel | 0.91984418 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.91859140 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.91664094 |
| 95 | * MP0005164_abnormal_response_to | 0.91622081 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.91057532 |
| 97 | * MP0000598_abnormal_liver_morphology | 0.90594102 |
| 98 | MP0002933_joint_inflammation | 0.90027193 |
| 99 | * MP0003795_abnormal_bone_structure | 0.89588208 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.88211024 |
| 101 | * MP0009763_increased_sensitivity_to | 0.88066388 |
| 102 | * MP0002429_abnormal_blood_cell | 0.87421250 |
| 103 | MP0001849_ear_inflammation | 0.87215449 |
| 104 | MP0001666_abnormal_nutrient_absorption | 0.87209201 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.87009981 |
| 106 | MP0004019_abnormal_vitamin_homeostasis | 0.86277294 |
| 107 | MP0003091_abnormal_cell_migration | 0.85605953 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.85475169 |
| 109 | MP0001663_abnormal_digestive_system | 0.85061961 |
| 110 | MP0005409_darkened_coat_color | 0.85059639 |
| 111 | MP0005332_abnormal_amino_acid | 0.84310136 |
| 112 | * MP0002405_respiratory_system_inflammati | 0.84139165 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.84115508 |
| 114 | * MP0001800_abnormal_humoral_immune | 0.83957443 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.83365006 |
| 116 | * MP0002722_abnormal_immune_system | 0.82704109 |
| 117 | MP0009115_abnormal_fat_cell | 0.82643743 |
| 118 | * MP0002723_abnormal_immune_serum | 0.82388398 |
| 119 | * MP0002998_abnormal_bone_remodeling | 0.81517770 |
| 120 | MP0004510_myositis | 0.78401007 |
| 121 | MP0003045_fibrosis | 0.78204680 |
| 122 | * MP0005165_increased_susceptibility_to | 0.77775327 |
| 123 | MP0001216_abnormal_epidermal_layer | 0.77636803 |
| 124 | MP0005076_abnormal_cell_differentiation | 0.77519293 |
| 125 | * MP0001851_eye_inflammation | 0.77401218 |
| 126 | MP0005508_abnormal_skeleton_morphology | 0.77370740 |
| 127 | * MP0000689_abnormal_spleen_morphology | 0.77064540 |
| 128 | * MP0003075_altered_response_to | 0.75767132 |
| 129 | MP0001873_stomach_inflammation | 0.74397862 |
| 130 | MP0000490_abnormal_crypts_of | 0.73507146 |
| 131 | MP0002896_abnormal_bone_mineralization | 0.68591290 |
| 132 | MP0002971_abnormal_brown_adipose | 0.68545028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.40506443 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 3.84789621 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.69430210 |
| 4 | Deep venous thrombosis (HP:0002625) | 3.59696280 |
| 5 | Complement deficiency (HP:0004431) | 3.56694898 |
| 6 | * Myositis (HP:0100614) | 3.48492647 |
| 7 | Xanthomatosis (HP:0000991) | 3.32154230 |
| 8 | Abnormality of complement system (HP:0005339) | 3.19672894 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.18989813 |
| 10 | Optic neuritis (HP:0100653) | 3.10639786 |
| 11 | * Orchitis (HP:0100796) | 3.10639786 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.10639786 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00450269 |
| 14 | Increased IgE level (HP:0003212) | 2.96684360 |
| 15 | Myocardial infarction (HP:0001658) | 2.95172574 |
| 16 | Increased connective tissue (HP:0009025) | 2.85580554 |
| 17 | Cerebral aneurysm (HP:0004944) | 2.80651185 |
| 18 | Joint hemorrhage (HP:0005261) | 2.77907591 |
| 19 | Abnormality of the nasal mucosa (HP:0000433) | 2.76469841 |
| 20 | Spontaneous hematomas (HP:0007420) | 2.75483159 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 2.72451299 |
| 22 | Vertebral compression fractures (HP:0002953) | 2.70881448 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69394061 |
| 24 | Obstructive lung disease (HP:0006536) | 2.69394061 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 2.65809120 |
| 26 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.62850239 |
| 27 | Glomerulonephritis (HP:0000099) | 2.61037874 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 2.60206666 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 2.56722172 |
| 30 | Aortic dissection (HP:0002647) | 2.56299892 |
| 31 | Hematochezia (HP:0002573) | 2.55846132 |
| 32 | Stomatitis (HP:0010280) | 2.54594996 |
| 33 | Ankle contracture (HP:0006466) | 2.52668117 |
| 34 | * Peritonitis (HP:0002586) | 2.51773185 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.46997507 |
| 36 | Aortic aneurysm (HP:0004942) | 2.45205861 |
| 37 | Cervical subluxation (HP:0003308) | 2.43486513 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 2.42901671 |
| 39 | Loss of speech (HP:0002371) | 2.42690533 |
| 40 | Recurrent bacterial skin infections (HP:0005406) | 2.42181565 |
| 41 | Broad metatarsal (HP:0001783) | 2.40577267 |
| 42 | Recurrent abscess formation (HP:0002722) | 2.40490934 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.40325264 |
| 44 | Recurrent skin infections (HP:0001581) | 2.39613926 |
| 45 | Intrahepatic cholestasis (HP:0001406) | 2.37391601 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.37146214 |
| 47 | Malnutrition (HP:0004395) | 2.37070772 |
| 48 | Esophageal varix (HP:0002040) | 2.36178369 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.34500682 |
| 50 | * Amyloidosis (HP:0011034) | 2.32307002 |
| 51 | Vascular tortuosity (HP:0004948) | 2.32232309 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.31561022 |
| 53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31561022 |
| 54 | Nephritis (HP:0000123) | 2.31534899 |
| 55 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.27741779 |
| 56 | Nonimmune hydrops fetalis (HP:0001790) | 2.27692363 |
| 57 | Abnormal cartilage morphology (HP:0002763) | 2.26471787 |
| 58 | Spondylolisthesis (HP:0003302) | 2.26305709 |
| 59 | Atrophic scars (HP:0001075) | 2.24500982 |
| 60 | Gingival bleeding (HP:0000225) | 2.22627358 |
| 61 | Hyperlipoproteinemia (HP:0010980) | 2.21872834 |
| 62 | Petechiae (HP:0000967) | 2.21772596 |
| 63 | Arterial tortuosity (HP:0005116) | 2.21148211 |
| 64 | Axonal loss (HP:0003447) | 2.21129944 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.20795660 |
| 66 | Meningitis (HP:0001287) | 2.20356548 |
| 67 | Nasal polyposis (HP:0100582) | 2.18517564 |
| 68 | Skin nodule (HP:0200036) | 2.18468476 |
| 69 | Mitral valve prolapse (HP:0001634) | 2.17434605 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.16857772 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16721067 |
| 72 | Mucopolysacchariduria (HP:0008155) | 2.16721067 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.16493239 |
| 74 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.16412965 |
| 75 | * Cellulitis (HP:0100658) | 2.16252351 |
| 76 | Multiple enchondromatosis (HP:0005701) | 2.14560534 |
| 77 | * Elevated erythrocyte sedimentation rate (HP:0003565) | 2.14499603 |
| 78 | Polycythemia (HP:0001901) | 2.12832325 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.12281685 |
| 80 | Prolonged partial thromboplastin time (HP:0003645) | 2.10415019 |
| 81 | Aneurysm (HP:0002617) | 2.10230909 |
| 82 | Hypercholesterolemia (HP:0003124) | 2.07980673 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.07980661 |
| 84 | Keratoconjunctivitis (HP:0001096) | 2.07423823 |
| 85 | Hemoptysis (HP:0002105) | 2.06477717 |
| 86 | Right ventricular cardiomyopathy (HP:0011663) | 2.04838250 |
| 87 | Pustule (HP:0200039) | 2.03488002 |
| 88 | Blue sclerae (HP:0000592) | 2.02824467 |
| 89 | Hypolipoproteinemia (HP:0010981) | 1.98855465 |
| 90 | Thin bony cortex (HP:0002753) | 1.98823130 |
| 91 | Shallow orbits (HP:0000586) | 1.98639194 |
| 92 | Increased variability in muscle fiber diameter (HP:0003557) | 1.96450746 |
| 93 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.95789737 |
| 94 | Periodontitis (HP:0000704) | 1.95425327 |
| 95 | Increased serum ferritin (HP:0003281) | 1.95180989 |
| 96 | Biconcave vertebral bodies (HP:0004586) | 1.95132806 |
| 97 | Mesangial abnormality (HP:0001966) | 1.94090939 |
| 98 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93736733 |
| 99 | Abnormal platelet function (HP:0011869) | 1.93426586 |
| 100 | Impaired platelet aggregation (HP:0003540) | 1.93426586 |
| 101 | Dilatation of the ascending aorta (HP:0005111) | 1.93055919 |
| 102 | Gingivitis (HP:0000230) | 1.92563523 |
| 103 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92354865 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92354865 |
| 105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92354865 |
| 106 | Hepatosplenomegaly (HP:0001433) | 1.91077453 |
| 107 | Generalized amyotrophy (HP:0003700) | 1.90651835 |
| 108 | * Vasculitis (HP:0002633) | 1.90443998 |
| 109 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.90128015 |
| 110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.90128015 |
| 111 | Abnormality of glycolipid metabolism (HP:0010969) | 1.90128015 |
| 112 | Joint stiffness (HP:0001387) | 1.90075163 |
| 113 | Hemorrhage of the eye (HP:0011885) | 1.89943706 |
| 114 | Hypertriglyceridemia (HP:0002155) | 1.89649566 |
| 115 | Polygenic inheritance (HP:0010982) | 1.88514276 |
| 116 | Encephalitis (HP:0002383) | 1.88438940 |
| 117 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.88358218 |
| 118 | Soft skin (HP:0000977) | 1.87018599 |
| 119 | Hyperammonemia (HP:0001987) | 1.87017150 |
| 120 | Epistaxis (HP:0000421) | 1.86664368 |
| 121 | Abnormality of macrophages (HP:0004311) | 1.86430790 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 1.86083206 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.85760618 |
| 124 | Fragile skin (HP:0001030) | 1.85518224 |
| 125 | Arterial thrombosis (HP:0004420) | 1.85195841 |
| 126 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83764677 |
| 127 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83764677 |
| 128 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83612575 |
| 129 | Hand muscle atrophy (HP:0009130) | 1.83546243 |
| 130 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82950111 |
| 131 | Abnormality of the Achilles tendon (HP:0005109) | 1.82685004 |
| 132 | Lymphangioma (HP:0100764) | 1.82236361 |
| 133 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.82079578 |
| 134 | Distal lower limb muscle weakness (HP:0009053) | 1.81336412 |
| 135 | Asymmetric septal hypertrophy (HP:0001670) | 1.81170017 |
| 136 | Urticaria (HP:0001025) | 1.80755670 |
| 137 | Epidermoid cyst (HP:0200040) | 1.79955670 |
| 138 | Acne (HP:0001061) | 1.79864993 |
| 139 | Ectopia lentis (HP:0001083) | 1.79779980 |
| 140 | Premature loss of primary teeth (HP:0006323) | 1.79475236 |
| 141 | Menorrhagia (HP:0000132) | 1.78342799 |
| 142 | Distal upper limb amyotrophy (HP:0007149) | 1.78174521 |
| 143 | Upper limb amyotrophy (HP:0009129) | 1.78174521 |
| 144 | Pathologic fracture (HP:0002756) | 1.78002975 |
| 145 | Purpura (HP:0000979) | 1.76674835 |
| 146 | Glomerulopathy (HP:0100820) | 1.75690252 |
| 147 | Abnormality of proline metabolism (HP:0010907) | 1.75556253 |
| 148 | Hydroxyprolinuria (HP:0003080) | 1.75556253 |
| 149 | Cardiovascular calcification (HP:0011915) | 1.72285819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.66753680 |
| 2 | TGFBR2 | 3.47961339 |
| 3 | PKN2 | 2.54490714 |
| 4 | RIPK4 | 2.38492110 |
| 5 | KDR | 2.25489513 |
| 6 | PRPF4B | 2.24333371 |
| 7 | FGFR4 | 2.16087687 |
| 8 | RIPK1 | 2.11176204 |
| 9 | TYK2 | 2.10579359 |
| 10 | TIE1 | 2.03838408 |
| 11 | SIK1 | 2.03461867 |
| 12 | TBK1 | 1.98566258 |
| 13 | EPHB1 | 1.95740143 |
| 14 | MAP2K3 | 1.87846704 |
| 15 | CDK12 | 1.83403340 |
| 16 | KIT | 1.82690010 |
| 17 | STK10 | 1.77346641 |
| 18 | * ERN1 | 1.73421804 |
| 19 | BCKDK | 1.71466543 |
| 20 | MAP3K3 | 1.70149252 |
| 21 | TTN | 1.69725545 |
| 22 | PTK6 | 1.64189887 |
| 23 | BLK | 1.63248281 |
| 24 | SMG1 | 1.61641464 |
| 25 | CSF1R | 1.60535523 |
| 26 | FLT3 | 1.48397696 |
| 27 | LRRK2 | 1.47993180 |
| 28 | EPHA3 | 1.47156528 |
| 29 | FES | 1.46802159 |
| 30 | PAK4 | 1.46737266 |
| 31 | PRKD2 | 1.46579259 |
| 32 | PIM2 | 1.46372133 |
| 33 | TESK2 | 1.45479261 |
| 34 | TAOK2 | 1.45146976 |
| 35 | MATK | 1.43348902 |
| 36 | GRK6 | 1.42430573 |
| 37 | NEK9 | 1.39012658 |
| 38 | MAP4K1 | 1.37146324 |
| 39 | CSK | 1.35051476 |
| 40 | PDGFRA | 1.35015035 |
| 41 | JAK3 | 1.29969990 |
| 42 | JAK1 | 1.27700209 |
| 43 | CDC42BPA | 1.27405249 |
| 44 | MST1R | 1.26626897 |
| 45 | ZAP70 | 1.26304203 |
| 46 | TGFBR1 | 1.24589014 |
| 47 | RPS6KA4 | 1.24442305 |
| 48 | MAP3K13 | 1.24008786 |
| 49 | FGFR3 | 1.23919439 |
| 50 | TNK2 | 1.23377174 |
| 51 | IRAK3 | 1.23129917 |
| 52 | PRKG2 | 1.22377369 |
| 53 | MAP3K10 | 1.20486266 |
| 54 | MAP3K6 | 1.18709719 |
| 55 | MAP3K14 | 1.17424111 |
| 56 | MOS | 1.13165674 |
| 57 | CAMK1D | 1.11507978 |
| 58 | IKBKB | 1.05082296 |
| 59 | BMX | 1.04082722 |
| 60 | FGR | 1.04015016 |
| 61 | IKBKE | 1.03419539 |
| 62 | PTK2 | 0.96621501 |
| 63 | PDPK1 | 0.94061886 |
| 64 | NME2 | 0.93830767 |
| 65 | KSR2 | 0.93818759 |
| 66 | IRAK4 | 0.92027616 |
| 67 | ICK | 0.90805056 |
| 68 | TAOK3 | 0.89910944 |
| 69 | MARK2 | 0.89178983 |
| 70 | JAK2 | 0.87980080 |
| 71 | EPHB2 | 0.85525427 |
| 72 | IRAK1 | 0.85374810 |
| 73 | BTK | 0.83106485 |
| 74 | DDR2 | 0.82590985 |
| 75 | EEF2K | 0.82515606 |
| 76 | ABL2 | 0.82122688 |
| 77 | PIK3CG | 0.80975501 |
| 78 | LATS1 | 0.80739578 |
| 79 | MAP3K11 | 0.80618318 |
| 80 | GRK1 | 0.78132559 |
| 81 | HCK | 0.77407162 |
| 82 | MAPKAPK3 | 0.76915854 |
| 83 | CDK6 | 0.76341071 |
| 84 | STK38 | 0.75983276 |
| 85 | SYK | 0.75337286 |
| 86 | PAK2 | 0.74441188 |
| 87 | SIK3 | 0.73474577 |
| 88 | LYN | 0.71827627 |
| 89 | LCK | 0.70477093 |
| 90 | CHUK | 0.70117095 |
| 91 | MAP3K2 | 0.67991577 |
| 92 | LATS2 | 0.67792314 |
| 93 | MAPK7 | 0.66566554 |
| 94 | RPS6KC1 | 0.65428276 |
| 95 | RPS6KL1 | 0.65428276 |
| 96 | RPS6KA2 | 0.65147423 |
| 97 | TEC | 0.64401628 |
| 98 | MYLK | 0.63736819 |
| 99 | PDK1 | 0.61997678 |
| 100 | TRPM7 | 0.61499614 |
| 101 | MET | 0.61326076 |
| 102 | EPHA2 | 0.60171317 |
| 103 | PTK2B | 0.58688117 |
| 104 | TESK1 | 0.58504759 |
| 105 | ITK | 0.58480923 |
| 106 | GRK5 | 0.56792197 |
| 107 | IRAK2 | 0.53425035 |
| 108 | RPS6KA6 | 0.50791451 |
| 109 | IGF1R | 0.49451798 |
| 110 | FER | 0.49417015 |
| 111 | MAPK11 | 0.48837706 |
| 112 | LMTK2 | 0.48666805 |
| 113 | MAPKAPK2 | 0.48536503 |
| 114 | MAP2K2 | 0.48481699 |
| 115 | ARAF | 0.48436672 |
| 116 | YES1 | 0.48392616 |
| 117 | RET | 0.48168199 |
| 118 | TAOK1 | 0.47918051 |
| 119 | MAPK12 | 0.47917342 |
| 120 | MAPK4 | 0.47438883 |
| 121 | MAP3K1 | 0.47094302 |
| 122 | PDGFRB | 0.46923081 |
| 123 | FYN | 0.46293025 |
| 124 | MTOR | 0.45843516 |
| 125 | CAMK4 | 0.45227479 |
| 126 | MAP3K7 | 0.44783277 |
| 127 | MAP2K6 | 0.44473602 |
| 128 | GSK3A | 0.44305649 |
| 129 | PIM1 | 0.43662156 |
| 130 | HIPK2 | 0.43615998 |
| 131 | DYRK1B | 0.42598440 |
| 132 | EGFR | 0.42231410 |
| 133 | GRK7 | 0.41825281 |
| 134 | STK3 | 0.41004891 |
| 135 | ABL1 | 0.40087859 |
| 136 | ILK | 0.39873702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02253062 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72449464 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.47582909 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.40486735 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.37693184 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36494163 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.98537213 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92302570 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.86744246 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72088379 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69271946 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.67307581 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65594505 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.63401453 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.56461233 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.54830516 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53863641 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53852098 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53157424 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52077931 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.51093037 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35473067 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34558195 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34046316 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28178312 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.27876532 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27453238 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.25184182 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24185778 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24030796 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.23407729 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22602933 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22100471 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19978097 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.18932428 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16531259 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16488195 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15910220 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14635765 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13546909 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09072468 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.08543795 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06775898 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05011001 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04682488 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04342911 |
| 47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.03926349 |
| 48 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99526734 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99281587 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99248114 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98587137 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97011307 |
| 53 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.93953146 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93807376 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.93440098 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92197487 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.91193224 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91118174 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.90722009 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89925543 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89152593 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89059181 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.88363948 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87462582 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85980638 |
| 66 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85815012 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85313464 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85240058 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82998335 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82641296 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.82425389 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82380534 |
| 73 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.81853160 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80607520 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79992965 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.79004159 |
| 77 | * TNF signaling pathway_Homo sapiens_hsa04668 | 0.78670685 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78615385 |
| 79 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.78424046 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77266881 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.76187423 |
| 82 | * Tuberculosis_Homo sapiens_hsa05152 | 0.75921485 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75658634 |
| 84 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75102994 |
| 85 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73361921 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.73213152 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72894466 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72711017 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.72496022 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72365829 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72245938 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71848349 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.71534508 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69855974 |
| 95 | * Insulin resistance_Homo sapiens_hsa04931 | 0.69281341 |
| 96 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69110336 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67881638 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67457755 |
| 99 | * Apoptosis_Homo sapiens_hsa04210 | 0.67382085 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66261530 |
| 101 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65797331 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65491752 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64994331 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64786337 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64303689 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64050811 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63799952 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63505368 |
| 109 | * Influenza A_Homo sapiens_hsa05164 | 0.63243881 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60221117 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.59539053 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59436526 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59023042 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58907872 |
| 115 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58769337 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57833692 |
| 117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56568987 |
| 118 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55300936 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.55288607 |
| 120 | * Hepatitis C_Homo sapiens_hsa05160 | 0.54501018 |
| 121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53823058 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53033587 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52992373 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52951646 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52140625 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51980591 |
| 127 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51594696 |
| 128 | Platelet activation_Homo sapiens_hsa04611 | 0.51184409 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50363487 |
| 130 | Lysine degradation_Homo sapiens_hsa00310 | 0.50351795 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.50308238 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50271526 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50196968 |
| 134 | Salmonella infection_Homo sapiens_hsa05132 | 0.49795011 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49492069 |
| 136 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48079674 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47184955 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44819158 |
| 139 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42734684 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41715597 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.41110756 |
| 142 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.40255727 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39864364 |

